|
|
Article: Maculopapular skin rashes associated with high-dose chemotherapy: prevalence and risk factors.(Clinical report)
- Article from:
- Oncology Nursing Forum
- Article date:
- November 1, 2006
- Author:
CopyrightCOPYRIGHT 2006 Oncology Nursing Society. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Purpose/Objectives: To determine the prevalence of and risk factors for maculopapular skin rashes associated with high-dose chemotherapy.
Design: Observational pilot study.
Setting: A bone marrow transplant hematology-oncology unit in a private city hospital.
Sample: Data were collected on 14 patients who developed maculopapular rashes out of 127 patients who received high-dose chemotherapy (purposive sampling).
Methods: Observation of the distribution and nature of skin rashes in relation to chemotherapy, disease, adjuvant medications, and white blood cell counts.
Main Research Variables: Diseases, chemotherapy protocols and ...